- Home
- APVO vs STSS Comparison
APVO vs STSS Comparison
Compare APVO & STSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APVO
- STSS
- Stock Information
- Founded
- APVO 2016
- STSS 2017
- Country
- APVO United States
- STSS United States
- Employees
- APVO N/A
- STSS N/A
- Industry
- APVO Biotechnology: Pharmaceutical Preparations
- STSS Medical/Dental Instruments
- Sector
- APVO Health Care
- STSS Health Care
- Exchange
- APVO Nasdaq
- STSS Nasdaq
- Market Cap
- APVO 4.9M
- STSS 5.1M
- IPO Year
- APVO N/A
- STSS 2022
- Fundamental
- Price
- APVO $1.57
- STSS $8.09
- Analyst Decision
- APVO Strong Buy
- STSS
- Analyst Count
- APVO 1
- STSS 0
- Target Price
- APVO $5,920.00
- STSS N/A
- AVG Volume (30 Days)
- APVO 176.9K
- STSS 3.4M
- Earning Date
- APVO 11-06-2025
- STSS 11-13-2025
- Dividend Yield
- APVO N/A
- STSS N/A
- EPS Growth
- APVO N/A
- STSS N/A
- EPS
- APVO N/A
- STSS N/A
- Revenue
- APVO N/A
- STSS $222,722.00
- Revenue This Year
- APVO N/A
- STSS N/A
- Revenue Next Year
- APVO N/A
- STSS N/A
- P/E Ratio
- APVO N/A
- STSS N/A
- Revenue Growth
- APVO N/A
- STSS N/A
- 52 Week Low
- APVO $1.41
- STSS $3.36
- 52 Week High
- APVO $381.10
- STSS $1,736.46
- Technical
- Relative Strength Index (RSI)
- APVO 47.04
- STSS 45.75
- Support Level
- APVO N/A
- STSS $8.75
- Resistance Level
- APVO $1.54
- STSS $10.93
- Average True Range (ATR)
- APVO 0.18
- STSS 2.33
- MACD
- APVO -0.02
- STSS -0.48
- Stochastic Oscillator
- APVO 57.55
- STSS 1.50
About APVO Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which targets co-stimulatory receptors and tumor antigens, and CD3xCD123, which is being developed as a potential treatment of frontline acute myelogenous leukemia. The company's preclinical candidates, APVO711, APVO0442, and APVO603, are being developed using the ADAPTIR modular protein technology platform. The company's versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.
About STSS Sharps Technology Inc.
Sharps Technology Inc is a medical device company. It offers syringes and other safety products. Sharps provensa, Securgard, and Sologard are ultra-low waste smart safety syringes designed to eliminate potentially infectious and accidental needlestick injuries.